These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 9751750

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of recombinant HLA-DR2 molecules. Replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows the assembly and secretion of soluble DR alpha beta heterodimers.
    Kalandadze A, Galleno M, Foncerrada L, Strominger JL, Wucherpfennig KW.
    J Biol Chem; 1996 Aug 16; 271(33):20156-62. PubMed ID: 8702739
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein.
    Smith KJ, Pyrdol J, Gauthier L, Wiley DC, Wucherpfennig KW.
    J Exp Med; 1998 Oct 19; 188(8):1511-20. PubMed ID: 9782128
    [Abstract] [Full Text] [Related]

  • 11. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW, Hafler DA, Strominger JL.
    Proc Natl Acad Sci U S A; 1995 Sep 12; 92(19):8896-900. PubMed ID: 7568039
    [Abstract] [Full Text] [Related]

  • 12. pH dependent binding of high and low affinity myelin basic protein peptides to purified HLA-DR2.
    Mukku PV, Passmore D, Phan D, Nag B.
    Mol Immunol; 1995 Jun 12; 32(8):555-64. PubMed ID: 7541890
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.
    Wucherpfennig KW, Catz I, Hausmann S, Strominger JL, Steinman L, Warren KG.
    J Clin Invest; 1997 Sep 01; 100(5):1114-22. PubMed ID: 9276728
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
    Godkin AJ, Smith KJ, Willis A, Tejada-Simon MV, Zhang J, Elliott T, Hill AV.
    J Immunol; 2001 Jun 01; 166(11):6720-7. PubMed ID: 11359828
    [Abstract] [Full Text] [Related]

  • 18. Anergy induction by dimeric TCR ligands.
    Appel H, Seth NP, Gauthier L, Wucherpfennig KW.
    J Immunol; 2001 Apr 15; 166(8):5279-85. PubMed ID: 11290814
    [Abstract] [Full Text] [Related]

  • 19. Functionally active recombinant alpha and beta chain-peptide complexes of human major histocompatibility class II molecules.
    Nag B, Arimilli S, Mukku PV, Astafieva I.
    J Biol Chem; 1996 Apr 26; 271(17):10413-8. PubMed ID: 8626615
    [Abstract] [Full Text] [Related]

  • 20. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.
    Pette M, Fujita K, Wilkinson D, Altmann DM, Trowsdale J, Giegerich G, Hinkkanen A, Epplen JT, Kappos L, Wekerle H.
    Proc Natl Acad Sci U S A; 1990 Oct 26; 87(20):7968-72. PubMed ID: 1700423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.